Investors might want to bet on Senseonics Holdings (SENS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, AscensiaPatient ...

Q4 2024 Earnings Call Transcript March 3, 2025 Senseonics Holdings, Inc. beats earnings expectations. Reported EPS is $-0.02, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We see our 365 day product as the catalyst for revenue growth, as well as for the future of blood glucose monitoring,” said Tim Goodnow, PhD, President and Chief Executive Officer of Senseonics.

GERMANTOWN, Md. (AP) — GERMANTOWN, Md. (AP) — Senseonics Holdings Inc. (SENS) on Monday reported a loss of $15.5 million in its fourth quarter. The Germantown, Maryland-based company said it ...

Senseonics Holdings ... For further information, please visit the Ascensia Diabetes Care website at: PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of ...

Eversense® 365 approved and launched in the U.S. during 2024 as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes Patient base increased 56% in ...